PortViewPortView
ENvue Medical logo

ENvue Medical (FEED) Stock Analysis

NASDAQHealthcareMedical - Specialties

$4.16-3.48%
1-year price historyRange $3.79 – $59.76
52-week range$4.16
$0.29$5.98

What ENvue Medical does

NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.

Key metrics

Market cap
$3.22M
P/E (TTM)
-0.03
EPS (TTM)
$-137.30
Beta
1.56
Dividend yield
0.00%
Revenue / share
$3.75
50-day avg
$4.00
200-day avg
$4.00
52-week high
$5.98
52-week low
$0.29
CEO
Doron Robert Besser

ETFs linked to FEED

Broad-market and Healthcare sector ETFs an investor holding ENvue Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how FEED fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze FEED in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for ENvue Medical?
ENvue Medical trades under the ticker FEED on NASDAQ.
Which exchange is FEED listed on?
FEED is listed on NASDAQ.
What sector does ENvue Medical operate in?
ENvue Medical is classified in the Healthcare sector (Medical - Specialties industry).
How can PortView help analyze FEED in a portfolio?
PortView shows FEED's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.